Skip links

Azilsartan K Medoxomil

Home / API - Commercial / Azilsartan K Medoxomil
CAS No.
863031-24-7
Therapeutic Category
Innovator Brand
EDARBI,EDARBYCLOR(WITH Chlorthalidone)
GMP
Available
DMF
Available
Filed
-
Under Filing
KFDA
Sample
Available
Indication

Azilsartan medoxomil is indicated for the treatment of hypertension in adults 18 years of age and older. It is approved for use alone or in combination with other antihypertensive drugs.

Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.

Send Enquiry